Article info
PDFInterventional cardiology
Original article
Clinical and intravascular imaging outcomes at 1 and 2 years after implantation of absorb everolimus eluting bioresorbable vascular scaffolds in small vessels. Late lumen enlargement: does bioresorption matter with small vessel size? Insight from the ABSORB cohort B trial
- Correspondence to Professor Patrick W Serruys, Interventional Cardiology Department, Erasmus MC, 's-Gravendijkwal 230, Rotterdam 3015 CE, The Netherlands; p.w.j.c.serruys{at}erasmusmc.nl
Citation
Clinical and intravascular imaging outcomes at 1 and 2 years after implantation of absorb everolimus eluting bioresorbable vascular scaffolds in small vessels. Late lumen enlargement: does bioresorption matter with small vessel size? Insight from the ABSORB cohort B trial
Publication history
- Received June 18, 2012
- Revised September 6, 2012
- Accepted September 19, 2012
- First published October 31, 2012.
Online issue publication
May 23, 2018
Article Versions
- Previous version (23 May 2018).
- Previous version (23 May 2018).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions